Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

Shares of Regeneron Pharmaceuticals Inc. REGN slid 1.35% to $564.64 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.07% to ...

LONDON - The England women's soccer team have returned home on Monday to a heroes' welcome following their Euro 2025 triumph, with government ministers hosting a reception to mark a victory hailed ...

WASHINGTON - The U.S. State Department has called for an immediate investigation into the recent death of a U.S. citizen in Syria, and there have been direct discussions with the Syrian government ...

Review the current Regeneron Pharmaceuticals Inc (REGN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if REGN is the best investment for you.

What the sigma? Some know “sigma” as the 18th letter of the Greek alphabet but it’s also teen slang for a cool dude.

This was the stock's third consecutive day of gains.